aTyr Pharma (LIFE) Reports Q1 Loss of $9.39/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. DECK
2. WDC
3. RNG
4. BYD
5. FIX
6. SPOT
7. BE
8. FCNCA
9. TSCO
10. WCN

Go back to aTyr Pharma (LIFE) Reports Q1 Loss of $9.39/Share

aTyr Pharma Announces First Quarter 2015 Operating Results

June 18, 2015 4:22 PM EDT

SAN DIEGO, June 18, 2015 /PRNewswire/ -- aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe rare diseases, today announced operating results for the first quarter 2015. The Company successfully completed its initial public offering following the end of the quarter on May 12, 2015, with estimated net proceeds of $76.9 million. Total cash and investments are expected to be approximately $145 million as of June 30, 2015. 

Proceeds raised during the first half of 2015 will be used to fund operations, including the ongoing Phase 1b/2 clinical trial of... More